TrumpRx expected to launch on Friday: report
Source: SeekingAlpha
2026-01-28 13:13:47 ET
More on leading drugmakers
- Novo Nordisk: Investors May Be In For An Earnings Surprise
- Pfizer: The Great Healthcare Plan Does Not Change My Bullish Stance
- Novo Nordisk: The Q4 Setup Favors Another Beat (Earnings Preview)
- Eli Lilly inks a gene-editing deal worth up to $1.12B with Seamless
- Novo ad spend for GLP-1s doubles that of Lilly in the U.S.: Reuters
Read the full article on Seeking Alpha
For further details see:
TrumpRx expected to launch on Friday: report
Merck KGAA
NASDAQ: MKGAF
MKGAF Trading
-7.08% G/L:
$122.316 Last:
673 Volume:
$124.224 Open:
MKGAF Latest News
July 22, 2025 09:00:00 pm
Crown Bioscience San Diego Achieves CLIA Certification to Enhance Clinical Trial Support
